Skip to main content

Nuvalent, Inc.

NUVLDelisted Jul 15, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001861560

Nuvalent, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 292 institutions reported holding it in 13F filings for Q2 2026, worth $9.29B in total; Soros Fund Management was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Nuvalent, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
4 insiders, $8.23M in total
Insiders trading
4
Net value
−$8.23M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Nuvalent, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Nuvalent, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Deerfield Management Company, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20263
Deerfield Mgmt L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Partners, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Flynn James EDirector, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20263
Deerfield Healthcare Innovations Fund, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Mgmt HIF, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Private Design Fund IV, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Mgmt IV, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Meyers Michael L.Director0Jul 15, 20262
Balcom AlexandraChief Financial Officer0Jul 15, 202614
Srivastava SapnaDirector0Jul 15, 20262
Oliger Christy J.Director0Jul 15, 20262
Squarer RonDirector0Jul 15, 20263
Turner Christopher DurantChief Medical Officer0Jul 15, 20262
Noci DarleneChief Development Officer0Jul 15, 202614
Lane BenjaminSee Remarks0Jul 15, 20262
Pelish Henry E.Chief Scientific Officer0Jul 15, 20268
Porter James RichardPresident and CEO0Jul 15, 20269
Miller Deborah AnnChief Legal Officer0Jul 15, 202612
Protopapas AnnaDirector0Jul 15, 20262
Bogle Grant C.Director0Jul 15, 20262
Wheeler CameronDirector0Jul 15, 20262
Shair MatthewDirector201,672IndirectNov 26, 20252
Pearlberg JosephDirector5,146Jun 20, 20250
Hack Andrew A. F.Director1,447,267IndirectDec 13, 20240
Conley EmilyDirector2,507Aug 27, 20240
Gilliland Dwight GaryDirector2,499Jun 14, 20240
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.10% Owner897,671Aug 3, 20210
Jackson Robert BowersDirector–Jul 30, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 15, 2025 (view filing)Oct 13-142 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−40.0K$87.36−$3.49M−39.3%61.7K after7 lots10b5-1
Oct 15, 2025 (view filing)Oct 13-142 daysPelish Henry E.Chief Scientific OfficerSSaleClass A Common Stock−10.1K$88.84−$894.6K−13.2%66.0K after4 lots10b5-1
Oct 3, 2025 (view filing)Oct 12 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−20.0K$85.48−$1.71M−24.5%61.7K after2 lots10b5-1
Oct 1, 2025 (view filing)Sep 29-302 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−27.6K$85.05−$2.35M−30.9%61.7K after2 lots10b5-1
Oct 1, 2025 (view filing)Sep 292 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.00K$83.07−$332.3K−7.7%48.0K after5 lots10b5-1
Sep 17, 2025 (view filing)Sep 152 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−27.0K$79.08−$2.14M−9.8%249.1K after3 lots10b5-1
Sep 12, 2025 (view filing)Sep 102 daysPelish Henry E.Chief Scientific OfficerSSaleClass A Common Stock−3.73K$78.83−$293.6K−5.3%66.0K after10b5-1
Aug 27, 2025 (view filing)Aug 252 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.00K$74.62−$298.5K−7.7%48.0K after3 lots10b5-1
Aug 19, 2025 (view filing)Aug 154 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−27.0K$75.42−$2.04M−9.8%249.1K after3 lots10b5-1
Aug 8, 2025 (view filing)Aug 71 dayPelish Henry E.Chief Scientific OfficerSSaleClass A Common Stock−5.50K$74.85−$411.7K−8.3%61.0K after10b5-1
Aug 1, 2025 (view filing)Jul 302 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.00K$80.36−$321.4K−7.7%48.0K after10b5-1
Jul 17, 2025 (view filing)Jul 15-162 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−20.0K$84.67−$1.69M−24.5%61.7K after5 lots10b5-1
Jul 17, 2025 (view filing)Jul 152 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−27.0K$82.27−$2.22M−9.8%249.1K after4 lots10b5-1
Jul 11, 2025 (view filing)Jul 9-102 daysPelish Henry E.Chief Scientific OfficerSSaleClass A Common Stock−7.64K$80.31−$614.0K−11.1%61.0K after4 lots10b5-1
Jul 1, 2025 (view filing)Jun 274 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−20.0K$80.02−$1.60M−24.5%61.7K after10b5-1
Jun 27, 2025 (view filing)Jun 261 dayNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.00K$78.71−$314.8K−7.7%48.0K after3 lots10b5-1
Jun 27, 2025 (view filing)Jun 25-272 daysPelish Henry E.Chief Scientific OfficerSSaleClass A Common Stock−10.8K$79.88−$862.7K−14.6%63.1K after2 lots10b5-1
Jun 17, 2025 (view filing)Jun 161 dayPorter James RichardPresident and CEOSSaleClass A Common Stock−27.0K$76.93−$2.08M−9.8%249.1K after3 lots10b5-1
Jun 10, 2025 (view filing)Jun 64 daysPelish Henry E.Chief Scientific OfficerSSaleClass A Common Stock−200$79.82−$16.0K−0.3%63.1K after10b5-1
May 30, 2025 (view filing)May 291 dayNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.00K$71.31−$285.2K−7.7%48.0K after2 lots10b5-1
May 16, 2025 (view filing)May 151 dayPorter James RichardPresident and CEOSSaleClass A Common Stock−27.0K$69.60−$1.88M−9.8%249.1K after3 lots10b5-1
May 1, 2025 (view filing)Apr 292 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.00K$74.56−$298.2K−7.7%48.0K after10b5-1
Apr 17, 2025 (view filing)Apr 152 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−27.0K$68.94−$1.86M−9.8%249.1K after4 lots10b5-1
Mar 28, 2025 (view filing)Mar 271 dayNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.00K$73.12−$292.5K−7.7%48.0K after2 lots10b5-1
Mar 19, 2025 (view filing)Mar 172 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−27.0K$75.87−$2.05M−9.8%249.1K after3 lots10b5-1
Mar 10, 2025 (view filing)Mar 6-74 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−34.0K$71.87−$2.44M−41.4%48.0K after5 lots10b5-1
Feb 25, 2025 (view filing)Feb 241 dayShair MatthewDirectorSSaleClass A Common Stock−2.00K$78.43−$156.9K−0.9%216.5K after3 lots10b5-1
Feb 20, 2025 (view filing)Feb 182 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−27.0K$78.46−$2.12M−9.8%249.1K after2 lots10b5-1
Jan 29, 2025 (view filing)Jan 272 daysShair MatthewDirectorSSaleClass A Common Stock−2.00K$82.79−$165.6K−0.9%218.5K after4 lots10b5-1
Jan 17, 2025 (view filing)Jan 152 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−27.0K$75.99−$2.05M−9.8%249.1K after4 lots10b5-1
Jan 8, 2025 (view filing)Jan 62 daysPelish Henry E.Chief Scientific OfficerSSaleClass A Common Stock−2.48K$79.68−$197.9K−4.0%60.0K after3 lots10b5-1
Jan 8, 2025 (view filing)Jan 62 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.02K$79.68−$320.0K−7.7%48.0K after3 lots10b5-1
Jan 8, 2025 (view filing)Jan 62 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−2.96K$79.68−$236.2K−5.7%49.1K after3 lots10b5-1
Jan 8, 2025 (view filing)Jan 62 daysTurner Christopher DurantChief Medical OfficerSSaleClass A Common Stock−4.02K$79.68−$320.0K−6.0%62.5K after3 lots10b5-1
Jan 8, 2025 (view filing)Jan 62 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−4.02K$79.68−$320.0K−6.1%61.7K after3 lots10b5-1
Jan 8, 2025 (view filing)Jan 62 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−17.3K$79.68−$1.38M−6.5%249.1K after3 lots10b5-1
Dec 26, 2024 (view filing)Dec 233 daysShair MatthewDirectorSSaleClass A Common Stock−2.00K$83.78−$167.6K−0.9%220.5K after2 lots10b5-1
Dec 18, 2024 (view filing)Dec 162 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−27.0K$86.61−$2.34M−12.6%188.1K after2 lots10b5-1
Dec 13, 2024 (view filing)Dec 112 daysHack Andrew A. F.DirectorSSaleClass A Common Stock−1.25M$88.00−$110.0M−46.3%1.45M after
Dec 3, 2024 (view filing)Nov 294 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−10.0K$95.79−$957.9K−23.1%33.3K after2 lots10b5-1
Nov 27, 2024 (view filing)Nov 252 daysShair MatthewDirectorSSaleClass A Common Stock−2.00K$96.22−$192.4K−0.9%222.5K after3 lots10b5-1
Nov 19, 2024 (view filing)Nov 154 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−27.0K$87.94−$2.37M−12.6%188.1K after4 lots10b5-1
Nov 4, 2024 (view filing)Nov 13 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−5.00K$88.60−$443.0K−13.1%33.3K after3 lots10b5-1
Nov 4, 2024 (view filing)Oct 314 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−10.0K$89.19−$891.9K−23.1%33.3K after4 lots10b5-1
Oct 30, 2024 (view filing)Oct 282 daysShair MatthewDirectorSSaleClass A Common Stock−2.00K$91.73−$183.5K−0.9%224.5K after3 lots10b5-1
Oct 24, 2024 (view filing)4:08 PM ETOct 222 daysDeerfield Management Company, L.P. and 7 othersDirector, 10% Owner, Other: * Director by deputizationSSaleClass A Common Stock−2.00M$97.75−$195.5M−18.7%8.67M after2 lots
Oct 17, 2024 (view filing)Oct 152 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−27.0K$102.28−$2.76M−12.6%188.1K after2 lots10b5-1
Oct 2, 2024 (view filing)Oct 11 dayNoci DarleneChief Development OfficerSSaleClass A Common Stock−5.00K$101.74−$508.7K−13.1%33.3K after6 lots10b5-1
Oct 2, 2024 (view filing)Sep 302 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−10.0K$101.06−$1.01M−23.1%33.3K after4 lots10b5-1
Sep 25, 2024 (view filing)Sep 232 daysShair MatthewDirectorSSaleClass A Common Stock−2.00K$102.75−$205.5K−0.9%226.5K after7 lots10b5-1